ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,324Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1187

$972K Total Retail Price of All Prescriptions

Rank: 29 out of 1187

400 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 400 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 11,664 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 537 444 1 2
LEVOTHYROXINE SODIUM 536 439 2 3
RISPERIDONE 536 374 2 58
QUETIAPINE FUMARATE 435 337 4 75
METOPROLOL TARTRATE 431 370 5 10
DIVALPROEX SODIUM 349 220 6 79
SIMVASTATIN 341 280 7 1
METFORMIN HCL 322 202 8 7
LISINOPRIL 317 277 9 4
DONEPEZIL HCL 308 266 10 26
FUROSEMIDE 308 271 10 8
OMEPRAZOLE 288 187 12 5
NAMENDA 265 252 13 44
GABAPENTIN 253 157 14 23
ATORVASTATIN CALCIUM 212 161 15 6
PANTOPRAZOLE SODIUM 211 175 16 42
SEROQUEL 174 127 17 189
TRAMADOL HCL 167 130 18 28
MIRTAZAPINE 166 155 19 54
OXYBUTYNIN CHLORIDE ER 153 101 20 118
WARFARIN SODIUM 148 138 21 13
LANTUS 147 136 22 77
HYDROCODONE-ACETAMINOPHEN 144 131 S3 23 20
LEVETIRACETAM 140 90 24 89
CARVEDILOL 139 120 25 19
HALOPERIDOL 138 86 26 136
TAMSULOSIN HCL 128 95 27 29
CLOPIDOGREL 126 122 28 33
PAROXETINE HCL 124 105 29 81
TRAZODONE HCL 121 91 30 63
ATENOLOL 120 72 31 18
VALPROIC ACID 107 79 32 183
IPRATROPIUM-ALBUTEROL 106 77 33 109
DIOVAN 100 94 34 17
PHENYTOIN SODIUM EXTENDED 92 63 35 173
MELOXICAM 90 67 36 49
IBUPROFEN 89 61 37 59
HYDROCHLOROTHIAZIDE 89 63 37 9
BENZTROPINE MESYLATE 88 35 R 39 133
PREDNISONE 88 61 39 61
POTASSIUM CHLORIDE 87 75 41 32
LITHIUM CARBONATE 86 0 42 195
FAMOTIDINE 86 63 42 48
METOPROLOL SUCCINATE 85 80 44 11
CYMBALTA 84 52 45 60
NOVOLOG 83 78 46 135
PLAVIX 83 74 46 52
OLANZAPINE 83 52 46 107
OXCARBAZEPINE 83 57 46 235
ACTOS 80 49 50 101
CARBIDOPA-LEVODOPA 79 67 51 99
AGGRENOX 77 38 52 299
KLOR-CON M20 77 71 52 93
TOPIRAMATE 74 24 54 161
LIPITOR 72 54 55 43
FINASTERIDE 71 71 56 110
ENALAPRIL MALEATE 71 33 56 27
ALENDRONATE SODIUM 68 57 58 25
SERTRALINE HCL 67 22 59 22
DIGOXIN 67 67 59 65
ESCITALOPRAM OXALATE 65 37 61 51
ZOLPIDEM TARTRATE 64 45 62 14
GLIPIZIDE 63 44 63 71
LYRICA 63 32 63 91
SPIRONOLACTONE 62 46 65 98
OLANZAPINE ODT 61 11 66 277
ZIPRASIDONE HCL 61 39 66 250
POLYETHYLENE GLYCOL 3350 61 46 66 86
OXYCODONE-ACETAMINOPHEN 60 48 S2 69 47
MEGESTROL ACETATE 58 56 R 70 185
AMOX TR-POTASSIUM CLAVULANATE 58 48 70 103
JANUVIA 58 53 70 34
PRAVASTATIN SODIUM 57 49 73 12
LOSARTAN POTASSIUM 55 55 74 21
DILTIAZEM HCL 54 54 75 388
GENERLAC 54 54 75 211
NITROFURANTOIN MONO-MACRO 54 49 75 221
ENULOSE 54 54 75 213
LAMOTRIGINE 52 33 79 163
DILTIAZEM 24HR CD 51 51 80 131
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 37 81 182
DIVALPROEX SODIUM ER 50 39 81 144
LEVOFLOXACIN 50 44 81 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.